Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical company focused on the development and ...

Managing weight loss with telotristat ethyl in patients with metastatic pancreatic ductal adenocarcinoma may improve survival ...

Opening plenary session features latest fetal fraction amplification researchSALT LAKE CITY, Jan. 29, 2025 (GLOBE NEWSWIRE) - ...

Bezuclastinib plus sunitinib showed favorable safety and efficacy in GIST, outperforming sunitinib alone in phase 3 Peak ...

Believe it or not, humans may not be drawn to reusable cup schemes due to a sense moral duty or good old-fashioned guilt. What's really going to draw them in, according to a new study, is gambling.

to conduct research. The delegation presented their findings at a poster session held by the Buffett Institute for Global Affairs on Friday. COP29 was held in Baku, Azerbaijan in November ...

Exelixis, Inc. (Nasdaq: EXEL) today announced results from a subgroup analysis of the phase 3 CABINET pivotal study of ...

One significant area of research is the shift in radio consumption habits due to the rise of on-demand content. A study found that listeners are increasingly turning to online radio, which allows ...

Zevra to receive a 2025 New Treatment Award for MIPLYFFA™ at the 21st Annual WORLDSymposiumEight abstracts discussing data and clinical ...

Feel free to contact the program leader, Distinguished Professor William A. Quinn, directly if interested email: wquinn@uark.edu. Or, contact the Kristen Collier Wright Office of Study Abroad and ...

Treatment with bezuclastinib plus Sutent led to safe and efficacious outcomes versus Sutent treatment alone in gastrointestinal stromal tumors.

Research reveals that most missing cats are found within a third of a mile (about 500 metres) of their escape point.